GSI 705 (Truvada 167 mg / 250 mg)

Generic Name: emtricitabine/tenofovir

This pill with imprint "GSI 705" is Blue, Capsule-shape and has been identified as Truvada 167 mg / 250 mg. It is supplied by Gilead Sciences, Inc..

Truvada is used in the treatment of pre-exposure prophylaxis; hiv infection; nonoccupational exposure; occupational exposure and belongs to the drug class antiviral combinations. There is no proven risk in humans during pregnancy. Truvada 167 mg / 250 mg is not a controlled substance under the Controlled Substance Act (CSA).

Truvada

Generic Name:

emtricitabine/tenofovir

Imprint:

GSI 705

Strength:

167 mg / 250 mg

Color:

Blue

Shape:

Capsule-shape

Availability:

Prescription only

Drug Class:

Antiviral combinations

Pregnancy Category:

B - No proven risk in humans

CSA Schedule:

Not a controlled drug

Labeler / Supplier:

Gilead Sciences, Inc.

National Drug Code (NDC):

61958-0705

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.